Ureterolithiasis disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: URT014 MIFTS: 34	Ureterolithiasis Categories: Nephrological diseases
Genes Tissues Related diseases Publications Drugs Expand all tables

Sources

Aliases & Classifications for Ureterolithiasis

MalaCards integrated aliases for Ureterolithiasis:

Name: Ureterolithiasis ¹² ⁴⁴ ¹⁵ ⁷³

Calculus of Ureter ¹²

Ureteric Calculus ¹²

Ureteral Calculi ⁷³

Ureteric Stone ¹²

Classifications:

MalaCards categories:
Anatomical: Nephrological diseases

See all MalaCards categories (disease lists)

ICD10: ³³

Diseases of the genitourinary system

Urolithiasis

Calculus of kidney and ureter

Calculus of ureter

External Ids:

Disease Ontology ¹² DOID:14146

ICD9CM ³⁵ 592.1

MeSH ⁴⁴ D053039

NCIt ⁵⁰ C114696

SNOMED-CT ⁶⁸ 31054009 95573009

ICD10 ³³ N20.1

UMLS ⁷³ C0041952 C1456865

Sources

Summaries for Ureterolithiasis

MalaCards based summary : Ureterolithiasis, also known as calculus of ureter, is related to nephrolithiasis, calcium oxalate and nephrolithiasis. An important gene associated with Ureterolithiasis is TRPV1 (Transient Receptor Potential Cation Channel Subfamily V Member 1). The drugs Tamsulosin and Alfuzosin have been mentioned in the context of this disorder. Affiliated tissues include kidney, adrenal gland and bone, and related phenotypes are behavior/neurological and renal/urinary system

Wikipedia : ⁷⁶ Kidney stone disease, also known as urolithiasis, is when a solid piece of material (kidney stone)... more...

Sources

Related Diseases for Ureterolithiasis

Diseases related to Ureterolithiasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 43)

#	Related Disease	Score
1	nephrolithiasis, calcium oxalate	11.5
2	nephrolithiasis	10.4
3	appendicitis	10.2
4	urinary tract obstruction	10.1
5	hydronephrosis	10.1
6	pyelonephritis	10.0
7	exstrophy of bladder	9.9
8	transitional cell carcinoma	9.9
9	angiomyolipoma	9.9
10	embryoma	9.9
11	ureterocele	9.9
12	cystinuria	9.9
13	adenine phosphoribosyltransferase deficiency	9.9
14	atrial fibrillation	9.9
15	papilloma	9.9
16	endometriosis	9.9
17	anuria	9.9
18	ureteral obstruction	9.9
19	dihydroxyadeninuria	9.9
20	renal dysplasia	9.9
21	fibromuscular dysplasia	9.9
22	thrombocytopenic purpura, autoimmune	9.9
23	vesicoureteral reflux 1	9.9
24	horns in sheep	9.9
25	brittle bone disorder	9.9
26	end stage renal failure	9.9
27	morbid obesity	9.9
28	systemic mastocytosis	9.9
29	small cell carcinoma	9.9
30	thrombosis	9.9
31	azoospermia	9.9
32	cystitis	9.9
33	ankylosis	9.9
34	gastroenteritis	9.9
35	glandular cystitis	9.9
36	teratoma	9.9
37	purpura	9.9
38	mastocytosis	9.9
39	uremia	9.9
40	acute pyelonephritis	9.9
41	adenoma	9.9
42	nephrogenic adenoma	9.9
43	actinomycosis	9.9

Comorbidity relations with Ureterolithiasis via Phenotypic Disease Network (PDN): (show all 12)

Acute Cystitis	Bladder Neck Obstruction
Hydronephrosis	Nephrolithiasis, Uric Acid
Nephrolithiasis, X-Linked Recessive, with Renal Failure	Paralytic Ileus
Prostate Cancer	Prostatic Hypertrophy
Pyelonephritis	Urethral Calculus
Urethral Stricture	Urinary Tract Obstruction

Graphical network of the top 20 diseases related to Ureterolithiasis:

Sources

Symptoms & Phenotypes for Ureterolithiasis

MGI Mouse Phenotypes related to Ureterolithiasis:

⁴⁶

#	Description	MGI Source Accession	Score	Top Affiliating Genes
1	behavior/neurological	MP:0005386	9.35	ADRA1A AKAP5 APBB1 APRT TRPV1
2	renal/urinary system	MP:0005367	8.92	ADRA1A APRT SLC12A3 TRPV1

Sources

Drugs & Therapeutics for Ureterolithiasis

Drugs for Ureterolithiasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 93)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Tamsulosin

Approved, Investigational

Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1

106133-20-4

129211

Alfuzosin

Approved, Investigational

Phase 4,Phase 3,Phase 2,Not Applicable

81403-80-7

2092

Ketorolac

Approved

Phase 4

66635-83-4, 74103-06-3

3826

Morphine

Approved, Investigational

Phase 4

57-27-2

5288826

Nefopam

Approved, Investigational

Phase 4

13669-70-0

Diclofenac

Approved, Vet_approved

Phase 4,Not Applicable

15307-86-5

3033

Ketoprofen

Approved, Vet_approved

Phase 4

22071-15-4

3825

Silodosin

Approved

Phase 4,Phase 3,Phase 2

160970-54-7

Acetaminophen

Approved

Phase 4,Phase 3,Not Applicable

103-90-2

1983

Ciprofloxacin

Approved, Investigational

Phase 4

85721-33-1

2764

Tadalafil

Approved, Investigational

Phase 4

171596-29-5

110635

Citric Acid

Approved, Nutraceutical, Vet_approved

Phase 4

77-92-9

311

Naftopidil

Investigational

Phase 4,Phase 3

57149-07-2

Adrenergic alpha-1 Receptor Antagonists

Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1

Neurotransmitter Agents

Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1

Adrenergic Antagonists

Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1

Adrenergic alpha-Antagonists

Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1

Adrenergic Agents

Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1

calcium channel blockers

Phase 4,Phase 3

Antihypertensive Agents

Phase 4,Phase 3

Calcium, Dietary

Phase 4,Phase 3

Platelet Aggregation Inhibitors

Phase 4,Phase 3

Ketorolac Tromethamine

Phase 4

Analgesics, Non-Narcotic

Phase 4,Not Applicable

Analgesics, Opioid

Phase 4,Not Applicable

Anti-Inflammatory Agents, Non-Steroidal

Phase 4,Not Applicable

Central Nervous System Depressants

Phase 4,Not Applicable

Analgesics

Phase 4,Phase 3,Not Applicable

Narcotics

Phase 4,Not Applicable

Antirheumatic Agents

Phase 4,Not Applicable

Peripheral Nervous System Agents

Phase 4,Phase 3,Not Applicable

Anti-Inflammatory Agents

Phase 4,Not Applicable

Cyclooxygenase Inhibitors

Phase 4,Not Applicable

Vasodilator Agents

Phase 4,Phase 3

Pharmaceutical Solutions

Phase 4,Not Applicable

Antipyretics

Phase 4,Not Applicable

Anti-Infective Agents

Phase 4,Not Applicable

Antibiotics, Antitubercular

Phase 4,Not Applicable

Anti-Bacterial Agents

Phase 4,Not Applicable

Cytochrome P-450 CYP1A2 Inhibitors

Phase 4

Cytochrome P-450 Enzyme Inhibitors

Phase 4

Topoisomerase Inhibitors

Phase 4

Cyclooxygenase 2 Inhibitors

Phase 4,Not Applicable

Sildenafil Citrate

Phase 4

171599-83-0

Phosphodiesterase Inhibitors

Phase 4

Phosphodiesterase 5 Inhibitors

Phase 4

Citrate

Phase 4

Prazosin

Approved

Phase 3

19216-56-9

4893

Nifedipine

Approved

Phase 3

21829-25-4

4485

Doxazosin

Approved

Phase 3

74191-85-8

3157

Interventional clinical trials:

(show top 50) (show all 81)

#	Name	Status	NCT ID	Phase	Drugs
1	Treatment of Upper Ureteric Stones	Unknown status	NCT02469766	Phase 4
2	The Use of Medical-Expulsive Therapy With Alfuzocine xl 10mg x1/d for Distal Ureterolithiasis.a Randomized Prospective Study	Unknown status	NCT00489112	Phase 4	Alfuzocine XL 10 mg once a day
3	Efficacy of Tamsulosin Oral-controlled Absorption System (OCAS) in the Treatment of Distal Ureteral Stones	Unknown status	NCT01167062	Phase 4	Tamsulosin Hydrochloride OCAS 0.4 mg
4	The Efficacy of Alpha-blockers for Expulsion of Distal Ureteral Stones	Unknown status	NCT00451061	Phase 4	Alfuzosin;Tamsulosin
5	Naftopidil 75mg for Improving Clearance of Urinary Stones	Unknown status	NCT02011737	Phase 4	naftopidil 75mg
6	Efficacy of Nefopam and Morphine in Balanced Analgesia for Acute Ureteric Colic	Unknown status	NCT01543165	Phase 4	Ketorolac and nefopam balanced analgesia;Balanced analgesia using ketorolac and morphine;Pain control with single analgesics (ketorolac)
7	Nefopam and Morphine Consumption in the Treatment of Ureteral Calculi	Completed	NCT00639574	Phase 4	Néfopam
8	Efficacy and Safety of Silodosin in the Treatment of Natural Expulsion in Patients With Ureteral Stones	Completed	NCT01533389	Phase 4	Silodosin;Placebo
9	Tamsulosin for Urolithiasis in the Emergency Dept	Completed	NCT00382265	Phase 4	tamsulosin
10	Efficacy Study of Different Analgesic Options in Kidney Stone Pain Management	Completed	NCT02187614	Phase 4	Diclofenac;Morphine;Paracetamol;Placebos
11	Antibiotic Prophylaxis Before Shock Wave Lithotripsy	Recruiting	NCT03692715	Phase 4	Ciprofloxacin;Placebo
12	Tamsulosin as Adjuvant Treatment Prior to Endoscopic Ureterolithotomy	Recruiting	NCT03614052	Phase 4	Tamsulosin Hydrochloride 0.4 MG;Placebo Oral Tablet
13	Phosphodiesterase 5 Inhibitors (PDE5i) (Sildenafil) as Medical Expulsive Therapy in Distal Ureteral Stones	Active, not recruiting	NCT02519153	Phase 4	Sildenafil
14	Trial of Tadalafil, Tamsulosin and Combination for Access Sheath Deployment	Enrolling by invitation	NCT03229889	Phase 4	Cialis 5Mg Tablet;Flomax 0.4Mg Capsule;Placebo
15	Silodosin Versus Tamsulosin for Treatment of Ureteral Stones	Terminated	NCT02369744	Phase 4	Silodosin;Tamsulosin
16	Celecoxib (Celebrex) in the Management of Acute Renal Colic	Withdrawn	NCT00304317	Phase 4	celecoxib
17	Alfuzosin for Medical Expulsion Therapy of Ureteral Stones	Unknown status	NCT00713739	Phase 3	Alfuzosin;nifedipine;doxazosin;prazosin
18	Evaluation of Tamsulosin in the Treatment of Ureteral Stones	Completed	NCT00151567	Phase 3	Tamsulosin;Placebo
19	Medical Expulsive Therapy for Ureter Stone Using Naftopidil	Completed	NCT01952314	Phase 3	Naftopidil 75mg;Placebo for Naftopidil;Standard treatment
20	Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi	Completed	NCT00177086	Phase 3
21	Effectiveness of Silodosin in Medical Expulsive Therapy for Ureteral Pelvic Stone From 4 to 10 mm.	Terminated	NCT02090439	Phase 3	Silodosin
22	Use of Alfuzosin in Stone Treatment With ESWL	Withdrawn	NCT00388271	Phase 3	Alfuzosin (Xatral);standard treatment
23	Comparing Patients After ESWL Treated With Ureteral Stents Versus Expulsion Therapy With Tamsulosin	Unknown status	NCT00478998	Phase 2	Tamsulosin
24	Does Treatment With Alfuzosin Increase Success Rates of (SWL) Shock Wave Lithotripsy	Unknown status	NCT00409227	Phase 2	Alpha blocker-alfuzosin;placebo
25	Study of Silodosin to Facilitate Passage of Urinary Stones	Completed	NCT01144949	Phase 2	silodosin;placebo
26	A Dose-finding Study of Silodosin in Patients With Urinary Calculi	Completed	NCT01539265	Phase 2	silodosin;silodosin;placebo
27	Mirabegron as Medical Expulsive Therapy (MET) for Ureteral Stones and Ureteral Stent Pain	Recruiting	NCT02744430	Phase 2	Mirabegron
28	Feasibility Study of the Uriprene Stent Following Uncomplicated Ureteroscopy	Completed	NCT02032316	Phase 1
29	Sterile Water Injections for Relieving Ureterolithiasis Pain	Unknown status	NCT01412840	Not Applicable
30	Silent Ureteral Stone: Impact on Renal Function and Kidney Anatomy	Unknown status	NCT01884870	Not Applicable
31	US-Non Contrast Computed Tomography Real-time Fusion for Urinary Stones Follow up	Unknown status	NCT02539004
32	Comparative Treatment Study in Patients With Lower Ureteral Stones	Unknown status	NCT00397397
33	Impact of Low Dose Fluoroscopy in Ureteroscopy	Unknown status	NCT02704949	Not Applicable
34	Shockwave Lithotripsy (SWL) Under Selective, General Anesthesia.	Unknown status	NCT01008267
35	Prospective Comparison Between Different Laser Settings for Ureteral \ Kidney Stones Treatment During Ureteroscopy	Unknown status	NCT02279927	Not Applicable
36	Intraureteral Lidocaine for Post-Ureteroscopy Pain	Unknown status	NCT01450566	Not Applicable	Lidocaine;Saline
37	Delayed or Direct Ureteroscopy in the Treatment of Pediatric Calcular Anuria	Unknown status	NCT02139059	Not Applicable
38	ESWL vs URS in Management of Upper Third Ureteric Calculi	Completed	NCT03559738
39	Comparing Uretersocopy With Versus Without Use of Guide-wire in Treatment of Ureteral Stone	Completed	NCT03726502	Not Applicable
40	The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in Emergency Department Patients	Completed	NCT00600405	Not Applicable	tamsulosin;Standard therapy with ibuprofen and oxycodone.
41	Study on 'The Use of Non-contrast Helical Computerized Tomogram in Predicting Treatment Outcomes of Upper Ureteric Stone by Extracorporeal Shock Wave Lithotripsy Using the Sonolith 4000+ Lithotripter'	Completed	NCT00517205
42	Medical Expulsive Therapy of Single Distal Ureteral Stones	Completed	NCT00831701	Not Applicable	Tamsulosin;Placebo
43	The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in Emergency Department Patients	Completed	NCT00448123	Not Applicable	Tamsulosin;Placebo
44	Management of Ureteral Calculi Using Ultrasound Guidance: A Radiation Free Approach	Completed	NCT01792765	Not Applicable
45	Effect of Tamsulosin on Stone Expulsion and Pain Resolution in ED Patients With Ureterolithiasis	Completed	NCT00762424	Not Applicable	Flowmax;placebo
46	Is Prophylactic Antibiotics Necessary In Otherwise Healthy Adult Patients Undergoing Ureteroscopic Procedures for Ureteral Stones?	Completed	NCT02635490
47	Use of the PercSys MicroStent Device to Alleviate Ureteral Stone Symptoms and Hydronephrosis	Completed	NCT01637519
48	Ureteral Stents Versus Percutaneous Nephrostomy for Initial Urinary Drainage	Completed	NCT02055430	Not Applicable
49	Role of Flexible Cystoscopy in Laparoscopic Stone Surgery	Completed	NCT01277198
50	The Usefulness of Flexible Cystoscopy for Preventing Double-J Stent Malposition After Laparoscopic Ureterolithotomy	Completed	NCT03150446	Not Applicable

Search NIH Clinical Center for Ureterolithiasis

Cochrane evidence based reviews: ureterolithiasis

Sources

Genetic Tests for Ureterolithiasis

Sources

Anatomical Context for Ureterolithiasis

MalaCards organs/tissues related to Ureterolithiasis:

⁴¹

Kidney, Adrenal Gland, Bone

Sources

Publications for Ureterolithiasis

Articles related to Ureterolithiasis:

(show top 50) (show all 99)

#	Title	Authors	Year
1	Bilateral ureterolithiasis: A true positive and false negative PoCUS exam in a patient with renal colic. ( 29606152 )		2018
2	Perinephric fat stranding is associated with elevated creatinine among patients with acutely obstructing ureterolithiasis. ( 29943669 )		2018
3	Acute synchronous appendicitis and obstructing ureterolithiasis. ( 30108673 )	Daniel SC...Khurana B	2018
4	CONTACT ULTRASOUND LITHOTRIPSY DURING URETEROLITHIASIS THERAPY. AN ANALYSIS OF LATE POSTOPERATIVE COMPLICATIONS. ( 30358535 )	Stetsyshyn R...Danylchenko S	2018
5	Narcotic Pain Control for Ureterolithiasis Is Associated With Unnecessary Repeat Imaging in the Emergency Department. ( 30358635 )	Garcia K...Sharma P	2018
6	Epidemiological and imaging features that can affect the detection of ureterolithiasis on ultrasound. ( 30369654 )	Nery DR...Baroni RH	2018
7	Spontaneous proximal ureteric rupture secondary to ureterolithiasis. ( 28069871 )	Pace K....German K.	2017
8	Ureterolithiasis: Management in an environment with limited facilities. ( 28513524 )		2017
9	Comparison between double-pigtail ureteral stents and ureteral bypass devices for treatment of ureterolithiasis in cats. ( 28763282 )		2017
10	Comparison of prone vs. supineA unenhanced CT imaging in patients with clinically suspected ureterolithiasis. ( 27670877 )	Meissnitzer M....Forstner R.	2016
11	Medical Expulsive Therapy for Ureterolithiasis: The EAU Recommendations in 2016. ( 27506951 )		2016
12	Beyond ureterolithiasis: gamut of abnormalities affecting the ureter. ( 27317212 )		2016
13	Is hydronephrosis on ultrasound predictive of ureterolithiasis in patients with renal colic? ( 27154825 )		2016
14	Management of Ureterolithiasis in a Patient with Crossed Unfused Renal Ectopia. ( 27403369 )		2016
15	Clinical relevance of seasonal changes in the prevalence of ureterolithiasis in the diagnosis of renal colic. ( 27314408 )	Fukuhara H...Tsuchiya N	2016
16	Long-term Adverse Effects of Extracorporeal Shock-wave Lithotripsy for Nephrolithiasis and Ureterolithiasis: A Systematic Review. ( 25917723 )	Fankhauser C.D....Steurer J.	2015
17	The use of alpha-1 adrenergic blockers in children with distal ureterolithiasis: a systematic review and meta-analysis. ( 26717117 )		2015
18	Tamsulosin for treatment of unilateral distal ureterolithiasis: a systematic review and meta-analysis. ( 24852587 )	Malo C....Turgeon A.F.	2014
19	Indwelling double pigtail ureteral stent combined or not with surgery for feline ureterolithiasis: complications and outcome in 15 cases. ( 24305471 )	Manassero M....Maurey C.	2013
20	Pyeloduodenal fistula due to proximal ureterolithiasis and its successful conservative management. ( 24051966 )	Fedorko M....NA9mcovA! E.	2013
21	Terpene compound drug as medical expulsive therapy for ureterolithiasis: a meta-analysis. ( 23503876 )		2013
22	Re: terpene compound drug as medical expulsive therapy for ureterolithiasis: a meta-analysis. ( 23421365 )		2013
23	Tamsulosin for treatment of unilateral distal ureterolithiasis: a systematic review and meta-analysis. ( 23870675 )		2013
24	Anuria and abdominal pain induced by ceftriaxone-associated ureterolithiasis in adults. ( 23180444 )		2013
25	Bladder bulge: unifying old and new sonographic bladder wall abnormalities in ureterolithiasis. ( 23358632 )	Bomann J.S....Rogers B.	2012
26	Bedside renal ultrasound in the evaluation of suspected ureterolithiasis. ( 21185667 )	Moak J.H....Lindsell C.J.	2012
27	Unusual presentation of bilateral ureteroceles with ureterolithiasis in a patient after robotic prostatectomy. ( 22546412 )	Lees T....Kella N.	2012
28	Synchronous obstructive ureterolithiasis and acute appendicitis. ( 24960802 )		2012
29	Endoscopic holmium laser treatment for ureterolithiasis. ( 24578918 )		2012
30	Health related quality of life in ureteral stone patients: post-ureterolithiasis. ( 21461963 )	Rabah D.M....Arafa M.A.	2011
31	Ureterolithiasis in children. ( 21585171 )		2011
32	The effect of alpha-blockade in emergency department patients with ureterolithiasis. ( 19217243 )	Watts H.F....Kulstad E.B.	2010
33	The sensitivity of transabdominal ultrasound in the diagnosis of ureterolithiasis. ( 21203595 )	MoA9 C....HA8lbac M.	2010
34	A case of calcified ureteritis cystica: an indiscernible condition from ureterolithiasis. ( 19655701 )	Alicioglu B....Atakan I.H.	2009
35	Acute onset of renal colic from bilateral ureterolithiasis: a case report. ( 19829794 )	Miranda EP...Scafuri AG	2009
36	Type IV ureteral triplication associated with ipsilateral ureterocele with ureterolithiasis and contralateral duplication with an ectopic ureteral orifice. ( 19138195 )	Park B.S.	2008
37	Conventional and reduced radiation dose of 16-MDCT for detection of nephrolithiasis and ureterolithiasis. ( 18094305 )	Paulson E.K....Frush D.P.	2008
38	Usefulness of urinalysis in following patients with distal ureterolithiasis. ( 18578655 )	Yoon G....Bellman G.	2008
39	The utility of unenhanced helical CT in assessing the frequency of ureterolithiasis in Saudi patients. ( 18246228 )	Al-Nakshabandi N.A....Al-Boukai A.A.	2008
40	Cost-effectiveness analysis (CEA) of intravenous urography (IVU) and unenhanced multidetector computed tomography (MDCT) for initial investigation of suspected acute ureterolithiasis. ( 18300151 )	Eikefjord E...R?rvik J	2008
41	Comparison between ultrasound and noncontrast helical computed tomography for identification of acute ureterolithiasis in a teaching hospital setting. ( 17625708 )		2007
42	Ureteroscopical treatment of ureterolithiasis in childhood. Our experience. ( 16752883 )		2006
43	Electro-acupuncture treatment for the upper segment ureterolithiasis under B-ultrasonography. ( 15889513 )		2005
44	Medical-expulsive therapy for distal ureterolithiasis: randomized prospective study on role of corticosteroids used in combination with tamsulosin-simplified treatment regimen and health-related quality of life. ( 16230122 )	Dellabella M...Muzzonigro G	2005
45	Ureterolithiasis after Cohen re-implantation--case report. ( 15070415 )	Chaudhary S....Buchholz N.N.	2004
46	Diagnostic value of attenuation measurements of the kidney on unenhanced helical CT of obstructive ureterolithiasis. ( 15100127 )	Goldman S.M....Szejnfeld J.	2004
47	Unenhanced helical CT of ureterolithiasis: incidence of secondary urinary tract findings. ( 15058632 )		2004
48	Unenhanced helical CT scan for ureterolithiasis. ( 15321049 )	Rafique MZ...Memon WA	2004
49	Pneumatic lithotripsy for ureterolithiasis: clinical analysis of 512 cases. ( 12865242 )	Chen Q.S....Liao J.X.	2003
50	Helical CT for nephrolithiasis and ureterolithiasis: comparison of conventional and reduced radiation-dose techniques. ( 14526095 )		2003

Sources

Genes for Ureterolithiasis

Genes related to Ureterolithiasis (0 elite genes):

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence
1	TRPV1	Transient Receptor Potential Cation Channel Subfamily V Member 1	Protein Coding	17.36	DISEASES inferred ¹⁵ ¹⁵
2	APRT	Adenine Phosphoribosyltransferase	Protein Coding	16.9	GeneCards inferred via : Publications (show sections)
3	SLC12A3	Solute Carrier Family 12 Member 3	Protein Coding	16.59	DISEASES inferred ¹⁵
4	ADRA1A	Adrenoceptor Alpha 1A	Protein Coding	16.34	DISEASES inferred ¹⁵
5	AKAP5	A-Kinase Anchoring Protein 5	Protein Coding	15.66	DISEASES inferred ¹⁵
6	APBB1	Amyloid Beta Precursor Protein Binding Family B Member 1	Protein Coding	14.8	DISEASES inferred ¹⁵

Sources

Variations for Ureterolithiasis

Sources

Expression for Ureterolithiasis

Search GEO for disease gene expression data for Ureterolithiasis.

Sources

Pathways for Ureterolithiasis

Sources

GO Terms for Ureterolithiasis

Cellular components related to Ureterolithiasis according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	dendritic spine	GO:0043197	8.62	AKAP5 APBB1

Biological processes related to Ureterolithiasis according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	positive regulation of cytosolic calcium ion concentration	GO:0007204	8.62	ADRA1A TRPV1

Molecular functions related to Ureterolithiasis according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	calmodulin binding	GO:0005516	8.62	AKAP5 TRPV1

Sources

Sources for Ureterolithiasis

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ ExPASy

¹⁸ FDA Approved Drugs

¹⁹ FMA

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ Genetics Home Reference

²⁶ GenomeRNAi

²⁷ GEO DataSets

²⁸ GO

²⁹ GTR

³⁰ HGMD

³¹ HMDB

³² HPO

³³ ICD10

³⁴ ICD10 via Orphanet

³⁵ ICD9CM

³⁶ IUPHAR

³⁷ KEGG

³⁸ LifeMap

³⁹ LncRNADisease

⁴⁰ LOVD

⁴¹ MalaCards

⁴² MedGen

⁴³ MedlinePlus

⁴⁴ MeSH

⁴⁵ MESH via Orphanet

⁴⁶ MGI

⁴⁷ miR2Disease

⁴⁸ NCBI Bookshelf

⁴⁹ NCI

⁵⁰ NCIt

⁵¹ NDF-RT

⁵² NIH Clinical Center

⁵³ NIH Rare Diseases

⁵⁴ NINDS

⁵⁵ Novoseek

⁵⁶ Novus Biologicals

⁵⁷ OMIM

⁵⁸ OMIM via Orphanet

⁵⁹ Orphanet

⁶⁰ PathCards

⁶¹ PharmGKB

⁶² PubMed

⁶³ PubMed Health

⁶⁴ QIAGEN

⁶⁵ R&D Systems

⁶⁶ Reactome

⁶⁷ Sino Biological

⁶⁸ SNOMED-CT

⁶⁹ SNOMED-CT via HPO

⁷⁰ SNOMED-CT via Orphanet

⁷¹ TGDB

⁷² Tocris

⁷³ UMLS

⁷⁴ UMLS via Orphanet

⁷⁵ UniProtKB/Swiss-Prot

⁷⁶ Wikipedia